SPR741

DRUG2 trials

Sponsors

Spero Therapeutics

Conditions

Healthy Volunteers

Phase 1

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers

CompletedNCT03022175

Spero TherapeuticsHealthy Volunteers

Start: 2016-12-31End: 2017-09-30Updated: 2017-10-05

Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

CompletedNCT03376529

Spero TherapeuticsHealthy Volunteers

Start: 2017-11-10End: 2017-12-20Updated: 2018-01-05

Related Papers

Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.

2019-08-2339 citations